Johnson & Johnson CEO on how close company is to coronavirus vaccine
Johnson & Johnson announced a lead COVID-19 vaccine candidate Monday morning. The company expects to begin phase one human clinical trials by September at the latest. Johnson & Johnson CEO Alex Gorsky joins “Squawk Box” to discuss.
Mon, Mar 30 20209:53 AM EST
This content was originally published here.